Industry | 2009.10.01
DiscoveRx Signs a Worldwide Agreement with GlaxoSmithKline (GSK) that Allows GSK Access to PathHunter™ ß-Arrestin Cell lines and Reagents for G-PCR Screening
FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corp. announced today the signing of a global agreement with GSK, a leading pharmaceutical company, to provide access to its PathHunter™ ß-Arrestin parental cell lines, clones and associated reagents for use in GSK’s internal GPCR Screening and Profiling efforts. The agreement was announced soon after the announcement of a major industrial/academic collaboration that includes Medical Research Council, GSK, and DiscoveRx around GPCR orp
For more information, please visit
http://www.businesswire.com/news/home/20091001005154/en
